FDA Gets $2.6 Billion to Finish Fiscal Year
President Barack Obama signed the fiscal year 2009 Ombnibus Appropriations Act on Mar. 11, 2009, giving the US Food and Drug Administration $2.6 billion. The funding can be used through the end of the fiscal year, Sept. 30, 2009.
President Barack Obama signed the fiscal year 2009 Omnibus Appropriations Act on Mar. 11, 2009, giving the US Food and Drug Administration $2.6 billion. The funding can be used through the fiscal year, which ends on Sept. 30, 2009.
Of the funds, $2 billion go directly to FDA. The Center for Drug Evaluation and Research will receive approximately $777 million for its activities and those of the Office of Regulatory Affairs (ORA), $41 million of which will go to the Office of Generic Drugs. The Center for Biologics Evaluation and Research will receive about $271 million for its activities and those of ORA. Approximately $511 million of the funding will come from prescription drug user fees.
In December 2007, Congress enacted the FY 2008 Omnibus Appropriations Act, which gave FDA $1.714 billion, and in June 2008, Congress gave the agency another $150 million as part of the FY 2008 emergency supplemental appropriations bill.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
